The Radials PET Imager is a groundbreaking versatile nuclear imaging system delivering high-resolution images with low radiotracer doses.
Developer of an organ-targeted positron emission tomography (PET) imaging system designed for high-definition and low-dose applications in oncology, neurology, and cardiology. The company's technology has ten times the efficiency for detecting radiotracer compared to traditional PET systems. The system has broad FDA clearance in the U.S. for imaging and measuring injected positron emitting radiopharmaceuticals. The current leading (reimburseable) indication is high resolution imaging of primary solid tumors for treatment planning, particularly as an adjunct to traditional staging PET/CT without additional radiotracer. The company is also pursuing targeted early detection of cancer and Alzheimer's disease with low-dose imaging in high-risk populations.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 13, 2021 | Debt Financing | $500K | 1 | FedNor | — | Detail |
Aug 11, 2020 | Grant | $434K | 1 | Northern Ontario Heritage Fund | — | Detail |
Mar 31, 2019 | Funding Round | $550K | 1 | Tenacity Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
FedNor | Yes | Debt Financing |
Northern Ontario Heritage Fund | Yes | Grant |
Tenacity Capital | Yes | Funding Round |